Glogovitis I, DAmbrosi S, Antunes-Ferreira M, Chiogna M, Yahubyan G, Baev V
Noncoding RNA. 2025; 11(1).
PMID: 39997617
PMC: 11858735.
DOI: 10.3390/ncrna11010017.
Chan C, Loh J, Sin W, Teo D, Tan N, Nagarajan C
Mol Ther Nucleic Acids. 2025; 36(1):102444.
PMID: 39897577
PMC: 11787021.
DOI: 10.1016/j.omtn.2024.102444.
Milhelm Z, Chiroi P, Harangus A, Dudea M, Ciocan C, Pop L
Med Pharm Rep. 2024; 97(4):438-445.
PMID: 39502766
PMC: 11534382.
DOI: 10.15386/mpr-2817.
Joshi U, George L, Highland H
Mol Biol Rep. 2024; 51(1):1041.
PMID: 39373748
DOI: 10.1007/s11033-024-09938-z.
Ben Hamouda M, Pearson A
Virus Genes. 2024; 60(5):537-548.
PMID: 39017941
DOI: 10.1007/s11262-024-02091-6.
Navigating the Modern Landscape of Sepsis: Advances in Diagnosis and Treatment.
Jang J, Choi E, Kim T, Yeo H, Jeon D, Kim Y
Int J Mol Sci. 2024; 25(13).
PMID: 39000503
PMC: 11242529.
DOI: 10.3390/ijms25137396.
Recent advances in gene delivery nanoplatforms based on spherical nucleic acids.
Valatabar N, Oroojalian F, Kazemzadeh M, Mokhtarzadeh A, Safaralizadeh R, Sahebkar A
J Nanobiotechnology. 2024; 22(1):386.
PMID: 38951806
PMC: 11218236.
DOI: 10.1186/s12951-024-02648-5.
Sample-to-answer salivary miRNA testing: New frontiers in point-of-care diagnostic technologies.
Zhang Z, Liu T, Dong M, Ahamed M, Guan W
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(3):e1969.
PMID: 38783564
PMC: 11141732.
DOI: 10.1002/wnan.1969.
Advancements in clinical RNA therapeutics: Present developments and prospective outlooks.
Saw P, Song E
Cell Rep Med. 2024; 5(5):101555.
PMID: 38744276
PMC: 11148805.
DOI: 10.1016/j.xcrm.2024.101555.
Advanced computational predictive models of miRNA-mRNA interaction efficiency.
Bader S, Tuller T
Comput Struct Biotechnol J. 2024; 23:1740-1754.
PMID: 38689718
PMC: 11058727.
DOI: 10.1016/j.csbj.2024.04.015.
A systematic review and meta-analysis of circulating serum and plasma microRNAs in TB diagnosis.
Gunasekaran H, Sampath P, Thiruvengadam K, Malaisamy M, Ramasamy R, Ranganathan U
BMC Infect Dis. 2024; 24(1):402.
PMID: 38622570
PMC: 11017603.
DOI: 10.1186/s12879-024-09232-0.
MicroRNA -21 expression as an auxiliary diagnostic biomarker of acute brucellosis.
Rezaeepoor M, Keramat F, Jourghasemi S, Rahmanpour M, Lipsa A, Hajilooi M
Mol Biol Rep. 2024; 51(1):264.
PMID: 38302783
DOI: 10.1007/s11033-023-09193-8.
Recent insights into the functions and mechanisms of antisense RNA: emerging applications in cancer therapy and precision medicine.
Ur Rehman S, Ullah N, Zhang Z, Zhen Y, Din A, Cui H
Front Chem. 2024; 11:1335330.
PMID: 38274897
PMC: 10809404.
DOI: 10.3389/fchem.2023.1335330.
miRNAs: Targets to Investigate Herpesvirus Infection Associated with Neurological Disorders.
de Souza Carneiro V, Leon L, de Paula V
Int J Mol Sci. 2023; 24(21).
PMID: 37958855
PMC: 10650863.
DOI: 10.3390/ijms242115876.
miRNAs in Neurological Manifestation in Patients Co-Infected with SARS-CoV-2 and Herpesvírus 6 (HHV-6).
de Souza Carneiro V, Moreira O, da Costa Nunes Pimentel Coelho W, Rio B, Sarmento D, Salvio A
Int J Mol Sci. 2023; 24(13).
PMID: 37446381
PMC: 10342854.
DOI: 10.3390/ijms241311201.
Identification of miRnas with possible prognostic roles for HAM/TSP.
de Souza D, Pessoa R, Nukui Y, Pereira J, Marcusso R, de Oliveira A
Virulence. 2023; 14(1):2230015.
PMID: 37394816
PMC: 10321194.
DOI: 10.1080/21505594.2023.2230015.
Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors.
Latini A, Vancheri C, Amati F, Morini E, Grelli S, Matteucci C
J Cell Mol Med. 2022; 26(19):4940-4948.
PMID: 36073344
PMC: 9538662.
DOI: 10.1111/jcmm.17492.
Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease.
Moatar A, Chis A, Marian C, Sirbu I
Int J Mol Sci. 2022; 23(16).
PMID: 36012503
PMC: 9409149.
DOI: 10.3390/ijms23169239.
RNA-based therapeutics: an overview and prospectus.
Zhu Y, Zhu L, Wang X, Jin H
Cell Death Dis. 2022; 13(7):644.
PMID: 35871216
PMC: 9308039.
DOI: 10.1038/s41419-022-05075-2.
Differential impact of the angiotensin-converting enzyme-2 (ACE2 rs4343 G>A) and miR-196a2 rs11614913 C>T gene alterations in COVID-19 disease severity and mortality.
Mir M, Mir R, Alghamdi M, Alsayed B, Elfaki I, Al Bshabshe A
Exp Ther Med. 2022; 23(6):418.
PMID: 35601073
PMC: 9117950.
DOI: 10.3892/etm.2022.11345.